Patents by Inventor William Shive

William Shive has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6723527
    Abstract: Disclosed are methods for assessment of the ability of substances to ameliorate the toxic-effects of compounds based on a lymphocyte culture assay. The lymphocyte assay is a repeatable and quantitative assay for lymphocyte growth in a chemically defined media in which specific compounds with potential toxicity and substances with potential abilities to ameliorate the toxicity can be added to determine specific and individualized requirements for such substances. Also disclosed are methods for ameliorating side-effects by administering to a patient undergoing therapy with a drug that has a toxic-effect, a substance identified by the methods of the invention. Further provided is a composition that ameliorates the toxic-effect of the statin family of drugs. Methods and processes for partially purifying and/or isolating this composition are also provided.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: April 20, 2004
    Assignee: Board of Regents, The University of Texas System
    Inventors: Flora H. Pettit, William Shive
  • Publication number: 20030087331
    Abstract: Disclosed are methods for assessment of the ability of substances to ameliorate the toxic-effects of compounds based on a lymphocyte culture assay. The lymphocyte assay is a repeatable and quantitative assay for lymphocyte growth in a chemically defined media in which specific compounds with potential toxicity and substances with potential abilities to ameliorate the toxicity can be added to determine specific and individualized requirements for such substances. Also disclosed are methods for ameliorating side-effects by administering to a patient undergoing therapy with a drug that has a toxic-effect, a substance identified by the methods of the invention. Further provided is a composition that ameliorates the toxic-effect of the statin family of drugs. Methods and processes for partially purifying and/or isolating this composition are also provided.
    Type: Application
    Filed: October 26, 2001
    Publication date: May 8, 2003
    Applicant: Board of Regents, The University of Texas System
    Inventors: Flora H. Pettit, William Shive, Gwyn Shive
  • Patent number: 4499064
    Abstract: Disclosed is a culture medium and methods for lymphocyte assessment of the nutritional status of humans by which repeatable and quantitative assays for deficiencies, abnormal requirements for or imbalances of vitamins, minerals and amino acids; for carbohydrate utilization, metabolism and imbalances and the like are obtained so that nutrition for each individual can be optimized thereby providing a significant impact on human health and productivity. Minimal amounts of lymphocytes and components of the culture medium are utilized making it possible to conduct a large number of nutritional assays with a small sample of blood.
    Type: Grant
    Filed: May 6, 1983
    Date of Patent: February 12, 1985
    Assignee: Clayton Foundation for Research
    Inventor: William Shive